A

Automated microinjection for zebrafish xenograft models

npj Biomedical Innovations., vol. 2

Abstract

Zebrafish xenograft models are increasingly recognized for predicting patient responses to cancer therapeutics, suggesting their potential as clinical diagnostic tools. However, precise microinjection of cancer cells into numerous small and fragile zebrafish larvae is laborious, requires extensive training for new operators, and often yields variable results, limiting their clinical and drug discovery applications. To address these challenges, we have designed, built, and validated an automated microinjection robot. The robot performs injections into the vasculature, perivitelline space, and hindbrain ventricle in both fully automated and semi-automated modes. Combined results demonstrate an average injection success rate of approximately 60% and larvae survival exceeding 70%, comparable to manual methods, with the fully automated mode being twice as fast. This automation reduces the need for extensive personnel training while enhancing reproducibility, efficiency, and accuracy, paving the way for more extensive use of zebrafish xenograft models in drug discovery and patient diagnostics.

Authors 20

  1. Affiliation as printed

    Life Science Methods BV, Leiden, the Netherlands

  2. Affiliation as printed

    Life Science Methods BV, Leiden, the Netherlands

  3. University of Oslo

    Affiliation as printed

    Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway

  4. ZeClinics (Spain)

    Affiliation as printed

    ZeClinics SL, Barcelona, Spain

  5. BioReperia AB (Sweden)

    Affiliation as printed

    BioReperia AB, Linköping, Sweden

  6. Leiden University Medical Center

    Affiliation as printed

    Oncode Institute, Dept. Cell & Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands

  7. Leiden University Medical Center

    Affiliation as printed

    Oncode Institute, Dept. Cell & Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands

  8. Leiden University Medical Center

    Affiliation as printed

    Oncode Institute, Dept. Cell & Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands

  9. Affiliation as printed

    Life Science Methods BV, Leiden, the Netherlands

  10. BioReperia AB (Sweden)

    Affiliation as printed

    BioReperia AB, Linköping, Sweden

  11. University of Oslo

    Affiliation as printed

    Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway

  12. University of Oslo

    Affiliation as printed

    Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway

  13. University of Michigan

    Affiliation as printed

    Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA

  14. University of Oslo

    Affiliation as printed

    Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway

  15. ZeClinics (Spain)

    Affiliation as printed

    ZeClinics SL, Barcelona, Spain

  16. ZeClinics (Spain)

    Affiliation as printed

    ZeClinics SL, Barcelona, Spain

  17. Leiden University Medical Center

    Affiliation as printed

    Oncode Institute, Dept. Cell & Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands

  18. University of Oslo

    Affiliation as printed

    Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway

  19. Linköping University · BioReperia AB (Sweden)

    Affiliation as printed

    BioReperia AB, Linköping, Sweden

    Division of Diagnostics and Specialist Medicine, Linköping University, Linköping, Sweden

  20. Leiden University Medical Center

    Affiliation as printed

    Life Science Methods BV, Leiden, the Netherlands. jan@lifesciencemethods.com

Cited by 10 stored of 10

10 results

No patents citing this paper on Lens.org (checked 2026-10-11).

References 56